DaVita
DVA
#1469
Rank
NZ$26.10 B
Marketcap
NZ$406.69
Share price
0.51%
Change (1 day)
72.39%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): NZ$18.80

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$18.63. In 2025 the company made an earnings per share (EPS) of NZ$17.14 a decrease over its 2024 EPS that were of NZ$18.68.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$18.809.66%
2025NZ$17.14-8.25%
2024NZ$18.6844.94%
2023NZ$12.8927.26%
2022NZ$10.13-35.56%
2021NZ$15.7244.1%
2020NZ$10.9119.7%
2019NZ$9.11540.48%
2018NZ$1.42-76.07%
2017NZ$5.95-19.31%
2016NZ$7.37242.52%
2015NZ$2.15-62.87%
2014NZ$5.7913.43%
2013NZ$5.118.45%
2012NZ$4.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$41.18 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$19.24 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$32.84 76.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.50-81.20%๐Ÿ‡บ๐Ÿ‡ธ USA